Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obatoclax Mesylate in Previously Untreated MDS
NCT00413114Phase 2Completed
- Sponsor
- Gemin X Pharmaceuticals
- Start
- Dec 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of obatoclax in myelodysplastic syndrome (MDS), sponsored by Gemin X Pharmaceuticals. Started Dec 2006; status: completed.
02
Drugs
obatoclax
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00413114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413114.